At the upcoming virtual event MD&M BIOMEDigital, Pat Baird, senior regulatory specialist and head of global software standards at Philips, will share some specific ways bad data can impact AI results.
The financing would enable Viz.ai to expand its artificial intelligence platform beyond stroke and into areas of acute care such as cardiology, pulmonary, and trauma.
The use of artificial intelligence in medical devices is on the rise. Although there is no specific directive or regulatory framework yet, AI decisions still need to be understandable and verifiable to ensure patient safety. TÜV SÜD shares key...
Pressed for time? Here's the medtech news you need most, in one minute or less.
Fast Company has published its annual list of the World’s Most Innovative Companies. How did your company rank?
Ibex Medical has raised $38 million in a Series B round to accelerate the adoption of the Galen platform, its AI-powered cancer diagnostic solution.
We've all heard these common industry buzzwords, but what do they even mean?
Trained dogs can detect cancer and other diseases through smell. Now, a miniaturized detector can analyze trace molecules to mimic the process